This common condition occurs when the eyes don’t produce enough tears or when those tears evaporate too quickly due to poor ...

Harrow is gaining momentum with VEVYE’s Access for All program, driving rapid prescription growth and revenue expansion in a ...

Patients with dry eye disease appear to have high satisfaction with perfluorohexyloctane compared with cyclosporine ophthalmic emulsion 0.05% ...

Common and emergency eye conditions could be treated on the high street under new rules to allow optometrists and opticians access to more medicines.

High street optometrists are set to gain expanded powers to treat common and emergency eye conditions under new government ...

Dry eye disease (DED) is a chronic inflammatory condition with increasing prevalence. Current treatment strategies, including artificial tears and anti-inflammatory agents, often fail to fully relieve ...

Millions of people suffer from dry eye disease, frequently due to meibomian gland dysfunction (MGD). According to Dr. April Jasper of Advanced Eye Care Specialists, “Dry eye disease occurs when tears ...

A Prescription Drug User Fee Act target date of December 16, 2025 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the second resubmitted New Drug ...

Please provide your email address to receive an email when new articles are posted on . This is the third new drug application for reproxalap that Aldeyra Therapeutics has submitted to the FDA. The ...